Literature DB >> 8353288

Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL.

D Lu1, J Liu, M Campbell, J Q Guo, N Heisterkamp, J Groffen, E Canaani, R Arlinghaus.   

Abstract

It is well established that the chimeric BCR-ABL gene formed by joining parts of the BCR and ABL genes plays a key role in the pathogenesis of Philadelphia (Ph) chromosome-positive leukemias. We report that simultaneous expression of P210 BCR-ABL and P160 BCR in simian COS-1 cells yielded stable complexes of these two proteins, and induced phosphorylation of P160 BCR on tyrosine residues in vivo. Tyrosine phosphorylation of a deletion mutant encoding 553 amino acids of BCR N-terminal sequences was also detected when it was coexpressed with P210 BCR-ABL. We propose that tyrosine phosphorylation of P160 BCR by P210 BCR-ABL and their stable physical interaction may perturb normal BCR functions and that these alterations are directly involved in the pathologic processes found in Ph chromosome-associated leukemias.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353288

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain.

Authors:  G Radziwill; R A Erdmann; U Margelisch; K Moelling
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

2.  Inhibition of Bcr serine kinase by tyrosine phosphorylation.

Authors:  J Liu; Y Wu; G Z Ma; D Lu; L Haataja; N Heisterkamp; J Groffen; R B Arlinghaus
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

3.  Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

Authors:  B Perazzona; H Lin; T Sun; Y Wang; R Arlinghaus
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

4.  Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS.

Authors:  Y Maru; K L Peters; D E Afar; M Shibuya; O N Witte; T E Smithgall
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

5.  BCR: a new target in resistance mediated by BCR/ABL-315I?

Authors:  Isabella Haberbosch; Anahita Rafiei; Claudia Oancea; Gerhart Oliver Ottmann; Martin Ruthardt; Afsar Ali Mian
Journal:  Genes Cancer       Date:  2016-01

6.  Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.

Authors:  L Puil; J Liu; G Gish; G Mbamalu; D Bowtell; P G Pelicci; R Arlinghaus; T Pawson
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.